Literature DB >> 20075214

Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco.

Robert J Smith1, Justin T Okano, James S Kahn, Erin N Bodine, Sally Blower.   

Abstract

Over the past two decades, HIV resistance to antiretroviral drugs (ARVs) has risen to high levels in the wealthier countries of the world, which are able to afford widespread treatment. We have gained insights into the evolution and transmission dynamics of ARV resistance by designing a biologically complex multistrain network model. With this model, we traced the evolutionary history of ARV resistance in San Francisco and predict its future dynamics. By using classification and regression trees, we identified the key immunologic, virologic, and treatment factors that increase ARV resistance. Our modeling shows that 60% of the currently circulating ARV-resistant strains in San Francisco are capable of causing self-sustaining epidemics, because each individual infected with one of these strains can cause, on average, more than one new resistant infection. It is possible that a new wave of ARV-resistant strains that pose a substantial threat to global public health is emerging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075214     DOI: 10.1126/science.1180556

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  51 in total

1.  HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites.

Authors:  Priya S Shah; Nhung P Pham; David V Schaffer
Journal:  Mol Ther       Date:  2012-01-31       Impact factor: 11.454

2.  HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.

Authors:  Michael J Boivin; Theodore D Ruel; Hannah E Boal; Paul Bangirana; Huyen Cao; Leigh A Eller; Edwin Charlebois; Diane V Havlir; Moses R Kamya; Jane Achan; Carolyne Akello; Joseph K Wong
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

3.  HIV treatment, preexposure prophylaxis, and drug resistance: reconciling conflicting predictions from mathematical models.

Authors:  Justin T Okano; Sally Blower
Journal:  J Infect Dis       Date:  2013-10-16       Impact factor: 5.226

4.  In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients.

Authors:  Mariana Leão de Lima-Stein; Wagner Tadeu Alkmim; Maria Clara de Souza Bizinoto; Luis Fernandez Lopez; Marcelo Nascimento Burattini; Juliana Terzi Maricato; Leila Giron; Maria Cecília Araripe Sucupira; Ricardo Sobhie Diaz; Luiz Mario Janini
Journal:  AIDS Res Hum Retroviruses       Date:  2014-08-25       Impact factor: 2.205

5.  Research highlights on a notable retrovirus and a popular guardian gene.

Authors:  Paraskevi Vogiatzi; Philip J Mason
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

Review 6.  Antiretroviral therapy: a key component of a comprehensive HIV prevention strategy.

Authors:  Mark W Hull; Julio Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2011-06       Impact factor: 5.071

Review 7.  Mathematical models for the study of HIV spread and control amongst men who have sex with men.

Authors:  Narat Punyacharoensin; William John Edmunds; Daniela De Angelis; Richard Guy White
Journal:  Eur J Epidemiol       Date:  2011-09-20       Impact factor: 8.082

8.  Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada.

Authors:  Viviane D Lima; Robert S Hogg; Julio S G Montaner
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

9.  Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.

Authors:  Luciano Vozzolo; Belinda Loh; Paul J Gane; Maryame Tribak; Lihong Zhou; Ian Anderson; Elisabeth Nyakatura; Richard G Jenner; David Selwood; Ariberto Fassati
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

10.  Test-and-treat in Los Angeles: a mathematical model of the effects of test-and-treat for the population of men who have sex with men in Los Angeles County.

Authors:  Neeraj Sood; Zachary Wagner; Amber Jaycocks; Emmanuel Drabo; Raffaele Vardavas
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.